PDL BioPharma Reports 2018 Fourth Quarter and Full Year Financial Results

March 15, 2019   |   March 2019 Bond Updates
INCLINE VILLAGE, Nev., March 14, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) reports financial results for the three and 12 months ended December 31, 2018: Financial Highlights Total revenues of $45.1 million for the 2018 fourth quarter and $198.1...

View more at: https://www.prnewswire.com:443/news-releases/pdl-biopharma-reports-2018-fourth-quarter-and-full-year-financial-results-300812778.html
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/